Colomer Bosch, Ramon ramon.colomer@uam.es
Actividades
- Artículos 257
- Libros 4
- Capítulos de libro 3
- Congresos 91
- Documentos de trabajo 1
- Informes técnicos 4
- Proyectos de investigación 1
- Tesis dirigidas 9
- Patentes o licencias de software 0
Gemcitabine in combination with paclitaxel for the treatment of metastatic breast cancer
- Ramon Colomer
Women's Health (London, England) (p. 323-329) - 1/11/2005
10.2217/17455057.1.3.323 Ver en origen
- ISSN 17455065
- iMarina
- iMarina
Development of a New Questionnaire to Assess Patient Perceptions of Cancer-Related Fatigue: Item Generation and Item Reduction
- Baro, Eva
- Carulla, Joan
- Cassinello, Javier
- Colomer, Ramon
- Mata, Jesus Garcia
- Gascon, Pere
- Gasquet, Jose Antonio
- Herdman, Michael
- Rodriguez, Cesar A
- Sanchez, Jordi
- Valentin, Vicente
Value In Health (p. 130-138) - 1/1/2009
10.1111/j.1524-4733.2008.00426.x Ver en origen
- ISSN 10983015
Prognostic value of cytosolic p53 protein in breast cancer
- Montero, S
- Guzman, C
- Vargas, C
- Ballestin, C
- Cortes-Funes, H
- Colomer, R;
Tumor Biology (p. 337-344) - 1/1/2001
10.1159/000050636 Ver en origen
- ISSN 10104283
P198 Prospective trans-GEICAM study of the impact of the 21-gene recurrence score assay and traditional clinico-pathological factors on clinical decision making in women with …
- J Albanell
- R Colomer
- M Ruiz-Borrego
- E Alba
- JA García Saenz
- M Martin
- I Tusquets
- F Rojo
- I Faull
- A Lluch
The Breast (p. S43-S43) - 1/1/2011
- iMarina
Psychometric properties of the Perform Questionnaire: a brief scale for assessing patient perceptions of fatigue in cancer
- Baro, Eva
- Carulla, Joan
- Cassinello, Javier
- Colomer, Ramon
- Garcia Mata, Jesus
- Gascon, Pere
- Antonio Gasquet, Jose
- Rodriguez, Cesar A
- Valentin, Vicente
Supportive Care In Cancer (p. 657-666) - 1/5/2011
10.1007/s00520-010-0878-x Ver en origen
- ISSN 09414355
Usefulness of the PERFORM questionnaire to measure fatigue in cancer patients with anemia: a prospective, observational study
- Gascon, Pere
- Rodriguez, Cesar A
- Valentin, Vicente
- Mata, Jesus Garcia
- Carulla, Joan
- Cassinello, Javier
- Colomer, Ramon
- Baro, Eva
Supportive Care In Cancer (p. 3039-3049) - 1/11/2013
10.1007/s00520-013-1862-z Ver en origen
- ISSN 09414355
A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
- Hitt, R
- Hornedo, J
- Colomer, R
- Mendiola, C
- Brandariz, A
- Sevilla, E
- AlvarezVicent, J
- CortesFunes, H;
Seminars In Oncology (p. 50-54) - 1/12/1995
- ISSN 00937754
- iMarina
Paclitaxel/gemcitabine administered every two weeks in advanced breast cancer: preliminary results of a phase II trial.
- Colomer, R
- Llombart, A
- Lluch, A
- Ojeda, B
- Barnadas, A
- Caranana, V
- Fernandez, Y
- De Paz, L
- Guillem, V
- Alonso, S;
Seminars In Oncology (p. 20-24) - 4/3/2000
- ISSN 00937754
- iMarina
DIRECT INTERACTION OF A LIGAND FOR THE ERBB2 ONCOGENE PRODUCT WITH THE EGF RECEPTOR AND P185ERBB2
Science (p. 1552-1555) - 1/1/1990
10.1126/science.2218496 Ver en origen
- ISSN 00368075
Consensus statement on biomarkers in breast cancer by the Spanish Society of Pathology and the Spanish Society of Medical Oncology
- Palacios Calvo J
- Albanell J
- Rojo F
- Ciruelos E
- Aranda-López I
- Cortés J
- García-Caballero T
- Martín M
- López-García M
- Colomer R
Revista Espanola De Patologia (p. 97-109) - 1/4/2018
10.1016/j.patol.2017.12.002 Ver en origen
- ISSN 1988561X
Safety of adjuvant treatment with pertuzumab plus trastuzumab after neoadjuvant anthracycline-based chemotherapy in patients with HER2-positive localized breast cancer: Updated …
- Chau Dang
- Michael S Ewer
- Suzette Delaloge
- Jean-Marc Ferrero
- Mark Verrill
- Ramon Colomer
- Claudia Vieira
- Luis de la Cruz Merino
- Jennifer Lucas
- Theresa L Werner
- Hannah Douthwaite
- Denise Bradley
- Maeve Waldron-Lynch
- Jennifer Eng-Wong
- Sandra M Swain
1/1/2018
- iMarina
Tratado de oncología
- Hernán Cortés-Funes
- Ramón Colomer Bosch
- Emilio Alba Conejo
1/1/2009
- ISBN 9788492620166
- iMarina
Are Inflammatory Markers Predictive of Nivolumab Efficacy in Advanced Non-Small-Cell Lung Cancer (NSCLC)?
- J Rogado
- MD Fenor De La Maza
- V Pacheco-Barcia
- JM Serra
- P Toquero
- B Vera
- A Ballesteros
- R Mondejar
- O Donnay
- B Obispo
- R Colomer
- JM Sanchez-Torres
1/1/2017
- iMarina
Tratamiento hormonal del cáncer
- Ramón Colomer Bosch
- M L Amador
- J González Cortijo
- MV Tornamira
Oncología En Atención Primaria / Coord. Por Vicente Valentín Maganto - 1/1/2003
- iMarina
Fatty acid metabolism in cancer cell survival: A new anti-cancer target
- Porta, Rut
- Colomer, Ramon
- Puig, Teresa;
Cell Respiration And Cell Survival: Processes, Types And Effects (p. 193-208) - 1/12/2011
- iMarina
Association of efficacy of anti-PD-1 immunotherapy in patients with advanced cancer with immune-related adverse events (irAEs)
- Rogado Revuelta, Jacobo
- Romero-Laorden, Nuria
- Sanchez Torres, Jose Miguel
- Pacheco-Barcia, Vilma
- Ballesteros, Anabel
- Maria Ramos-Levi, Ana
- Arranz, Reyes
- Lorenzo, Alicia
- Gullon, Pedro
- Garrido Garcia, Ana
- Maria Serra, Jose
- Donnay, Olga
- Adrados, Magdalena
- Costas, Pablo
- Aspa, Javier
- Alfranca, Arantza
- Fenor De la Maza, Maria Dolores
- Mondejar, Rebeca
- Colomer, Ramon;
Journal Of Clinical Oncology - 1/1/2019
- ISSN 0732183X
- iMarina
Epoetin beta in patients with metastatic breast cancer receiving chemotherapy: Results from the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study.
Journal Of Clinical Oncology (p. 467-764S) - 1/1/2005
- ISSN 0732183X
- iMarina
Phase II, 3-arm study of CCI-779 in combination with letrozole in postmenopausal women with locally advanced or metastatic breast cancer: Preliminary results
- J Baselga
- P Fumoleau
- M Gil
- R Colomer
- H Roche
- H Cortes-Funes
- H Burstein
- P Kaufman
- S Kong
- L Moore
Journal Of Clinical Oncology (p. 467-13S) - 1/1/2004
- ISSN 0732183X
- iMarina
Efficacy and CNS progression analysis from the randomized phase 2 trial of neratinib plus paclitaxel vs trastuzumab plus paclitaxel as first-line treatment for HER2+metastatic breast cancer (NEfERTT)
- Awada, Ahmad
- Colomer, Ramon
- Bondarenko, Igor
- Inoue, Kenichi
- Badwe, Rajendra A.
- Demetriou, Georgia
- Wang, Xiaojia
- Smirnov, Vitaly
- Lee, Soo-Chin
- Mehta, Ajay O.
- Kim, Sung-Bae
- Shen, Zhen-Zhou
- Bachelot, Thomas Denis
- Goswami, Chanchal
- Deo, S. V. S.
- Bose, Ron
- Wong, Alvin
- Xu, Feng
- Bryce, Richard
- Carey, Lisa A.;
Journal Of Clinical Oncology - 1/1/2015
10.1200/jco.2015.33.15_suppl.610 Ver en origen
- ISSN 0732183X
Validation of a new questionnaire to assess the patient perception of cancer-related fatigue (CRF): The Perform Questionnaire (PQ)
- Rodriguez, C.
- Gascon, P.
- Garcia-Mata, J.
- Colomer, R.
- Cassinello, J.
- Carulla, J.
- Valentin, V.
- Baro, E.
- Gasquet, J. A.
- Sanchez, J.;
Journal Of Clinical Oncology - 1/1/2007
- ISSN 0732183X
- iMarina
Randomized 3-arm, phase 2 study of ternsirolimus (CCI-779) in combination with letrozole in postmenopausal women with locally advanced or metastatic breast cancer.
- JT Carpenter
- H Roche
- M Campone
- R Colomer
- A Jagiello-Gruszfeld
- L Moore
- M D'Amore
- S Kong
- J Boni
- J Baselga
Journal Of Clinical Oncology (p. 467-19S) - 1/1/2005
- ISSN 0732183X
- iMarina
Prevalence and management of anemia in patients with non-myeloid tumors undergoing systemic therapy.
- Steegmann, J.
- Sanchez, J.
- Colomer, R.
- Vaz, M.
- Lopez Jimenez, J.
- Jalon, I.
- Provencio, M.
- Gonzalez Martin, A.
- Perez, M.;
Journal Of Clinical Oncology - 1/1/2010
10.1200/jco.2010.28.15_suppl.e19658 Ver en origen
- ISSN 0732183X
Epidermal growth factor receptor (EGFR)-activating mutations (mut) and response to gefitinib in lung adenocarcinoma.
- Cortes-Funes, H
- Almanza, C
- Valero, P
- Giron, CG
- Velasco, A
- Colomer, R
- Camps, C
- Diz, P
- Taron, M
- Rosell, R;
Journal Of Clinical Oncology (p. 467-639S) - 1/1/2005
- ISSN 0732183X
- iMarina
Phase I trial of the combination of the multikinase inhibitor nintedanib plus letrozole: A window of opportunity trial in adjuvant hormone-receptor positive breast cancer (HRPBC).
- Rodriguez, Laura Medina
- Guerra, Juan Antonio
- Malon, Diego
- Laura, Rodriguez
- Colomer, Ramon
- Quintela-Fandino, Miguel;
Journal Of Clinical Oncology - 1/1/2016
10.1200/jco.2016.34.15_suppl.tps615 Ver en origen
- ISSN 0732183X
Determining the clinical significance of the improvement in health-related quality of life (HRQoL) measures in oncology patients
- Cassinello, J
- Carulla, J
- Valentin, V
- Rodriguez, C A
- Gascon, P
- Garcia-Mata, J
- Colomer, R
- Baro, E
- Gasquet, J A
Journal Of Clinical Oncology - 1/1/2008
10.1200/jco.2008.26.15_suppl.20622 Ver en origen
- ISSN 0732183X
[Generalized cutaneous-nodal metastatic spread as initial manifestation of the recurrence of a gastric adenocarcinoma]
- Sanchez-Munoz, A
- Gravalos Castro, C
- Colomer Bosch, R
- Garcia Velasco, A
- Garcia, J P
- Cortes-Funes, H
Revista Clinica Espanola (p. 597-598) - 1/1/2003
- ISSN 15781860
- iMarina
Phase I/II study of paclitaxel/cisplatin as first-line therapy for locally advanced head and neck cancer.
- Hitt, R
- Paz-Ares, L
- Hidalgo, M
- Colomer, R
- Brandariz, A
- Pena, M
- Alvarez-Vicent, J
- Hornedo, J
- Cortes-Funes, H;
Seminars In Oncology (p. S19-20) - 1/12/1997
- ISSN 00937754
- iMarina
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
- Johnston SRD, Harbeck N, Hegg R, Toi M, Martin M, Shao ZM, Zhang QY, Martinez Rodriguez JL, Campone M, Hamilton E, Sohn J, Guarneri V, Okada M, Boyle F, Neven P, Cortés J, Huober J, Wardley A, Tolaney SM, Cicin I, Smith IC, Frenzel M, Headley D, Wei R, San Antonio B, Hulstijn M, Cox J, O'Shaughnessy J, Rastogi P, monarchE Committee Members and Investigators
Journal Of Clinical Oncology (p. 3987-3998) - 1/12/2020
- ISSN 0732183X
- iMarina
Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomization
- Arranz, R.
- García-Alfonso, P.
- Sobrino, P.
- Zamora, P.
- Carrión, R.
- García-Laraña, J.
- Pérez, G.
- López, J.
- Lavilla, E.
- Lozano, M.
- Rayón, C.
- Colomer, R.
- González Barón, M.
- Flores, E.
- Pérez-Manga, G.
- Fernández-Rañada, J.M.
Journal Of Clinical Oncology (p. 1538-1546) - 1/1/1998
Editor: American Society of Clinical Oncology
10.1200/jco.1998.16.4.1538 Ver en origen
- ISSN 0732183X
- ISSN/ISBN 0732-183X
- Dialnet
- iMarina
A phase II study of sequential docetaxel followed by doxorubicin/cyclophosphamide as first-line chemotherapy for metastatic breast cancer
- Antón A, Hornedo J, Lluch A, Massuti B, Corral M, Colomer R
Clinical Breast Cancer (p. 286-91) - 1/1/2003
10.3816/cbc.2003.n.034 Ver en origen
- ISSN 15268209
Índice de Respuesta Inflamatoria Sistémica (IRIS): Factor Pronóstico en el Cáncer de Páncreas
- Rebeca Mondéjar Solís (Director)
- Ramón Colomer Bosch (Director) Doctorando: Pacheco Barcia, Vilma Emilia
28/1/2021
- iMarina
Cambios en el perfil inmunohistoquímico tras tratamiento neoadyuvante en pacientes con cáncer de mama
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Miguel Martín Giménez (Director) Doctorando: Rebeca Mondéjar Solís
1/1/2016
- iMarina
El fenotipo basal-her2 en el cáncer de mama: caracterización clínico-molecular e implicaciones terapéuticas
- Colomer Bosch, Ramon (Autor o Coautor)
- Javier Abel Menéndez Menéndez (Director)
- Ramón Colomer Bosch (Director) Doctorando: Begoña Martín Castillo
1/1/2016
- iMarina
Efectos de la inhibición de la síntesis de ácidos grasos en la eficacia de los tratamientos antineoplásicos
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director) Doctorando: Alejandro Vázquez Martín
1/1/2007
- iMarina
Estudio fase i/ii con dosis altas de mitoxantrone y ciclofosfamida sin soporte hematopoyético para el tratamiento de tumores de alto riesgo y metastásicos
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Rafael Enríquez de Salamanca (Director) Doctorando: José Luis Pérez Gracia
1/1/2004
- iMarina
Características y evolución del cáncer de mama metástásico al diagnóstico: comparación con las recidivas del cáncer de mama inicialmente localizado
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Rafael Enríquez de Salamanca (Director) Doctorando: Antonio Jimeno Largo
1/1/2003
- iMarina
Importancia de la dosis de antraciclinas en el tratamiento adyuvante del cáncer de mama
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Rafael Enríquez de Salamanca Lorente (Director) Doctorando: María Luz Amador Muñoz
1/1/2002
- iMarina
Ácidos grasos en la progresión del cáncer de mama: implicaciones terapéuticas
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director) Doctorando: Javier Abel Menéndez Menéndez
1/1/2001
- iMarina
Utilidad de la expresión de p53 en tumores de mama como factor pronóstico y predictor de la respuesta al tratamiento
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director) Doctorando: Cecilia Guzman Zapater
1/1/1996
- iMarina
Este/a investigador/a no tiene patentes o licencias de software.
Perfiles de investigador/a
-
ORCID
-
Publons
-
Scopus Author ID
-
Dialnet id